Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Life Medical Sciences' Repel

This article was originally published in The Gray Sheet

Executive Summary

Pivotal trial in the U.S. employing the bioresorbable copolymer gel for prevention or reduction of adhesions following gynecological surgery will include 140 patients at roughly 14 sites and is slated to begin in the third quarter. Edison, New Jersey-based LMS announced investigational device exemption clearance April 30. Pilot study data show the product to be twice as effective in reducing adhesion formation compared to the control of standard surgical treatment; the device was particularly effective in treating adhesion formation on the posterior surface of the uterus ("The Gray Sheet" Dec. 22, In Brief). LMS is conducting a pilot study for Repel-CV for prevention of adhesions following cardiovascular surgery ("The Gray Sheet" March 30, p. 24) and has completed preclinical studies on Resolve, a bioresorbable viscous solution for reducing post-operative adhesions in gynecological and general abdominal surgeries. Preclinical studies are ongoing for Relieve gel for orthopedic use
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009988

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel